Labcorp to Webcast Its Annual Meeting of Shareholders May 15

BURLINGTON, N.C., May 8, 2025 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that its Annual Meeting of Shareholders will be webcast live on May 15 at 9:00 a.m. ET and can be viewed online on the Labcorp Investor Relations website. An archived replay of the webcast will be available for one year.

About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company’s nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved in 2024 by the FDA, and perform more than 700 million tests annually for patients around the world. Learn more about us at www.labcorp.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-webcast-its-annual-meeting-of-shareholders-may-15-302450229.html

SOURCE Labcorp Holdings Inc

Staff

Recent Posts

Aleen Inc. Insights: Understanding Your Personal Wellness Patterns

Toronto, Ontario--(Newsfile Corp. - December 16, 2025) - Aleen Inc. (CSE: ALEN.U), a digital wellness…

38 minutes ago

InstantGMP Modernizes Software Validation with FDA Computer Software Assurance-Aligned Approach

CARY, N.C., Dec. 16, 2025 /PRNewswire/ -- InstantGMP™, a provider of cloud-based GMP and FDA…

3 hours ago

Hamilton Launches GlucoSense, a First-of-Its-Kind, Real-Time, In Situ Glucose Sensor for Mammalian Cell Culture

BONADUZ, Switzerland, Dec. 16, 2025 /PRNewswire/ -- Hamilton today announced the launch of GlucoSense, a…

3 hours ago

CTT Pharma’s Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics

TAMPA, FL / ACCESS Newswire / December 16, 2025 / (OTCQB:CTTH) CTT Pharmaceutical Holdings, Inc.…

3 hours ago

Genflow Completes Dosing Phase of Canine Gene Therapy Trial

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION…

6 hours ago